At BioPharma Ambition in Dublin Castle, we spoke to GSK’s Dr Bernadette Doyle about how digital transformation has changed the talent pipeline challenges for this sector.

The inaugural BioPharma Ambition Conference was held in Dublin in September 2016, with international policy leaders, renowned researchers and senior industry personnel coming together to discuss hot industry topics such as digital transformation and its implications. editor John Kennedy spoke to Dr Bernadette Doyle, vice-president of global technical and NPI, global manufacturing and supply at GlaxoSmithKline, about the changing nature of skills in the pharmachem sector and the challenges in building a strong, diverse pipeline of talent.

BioPharma Ambition returns to Dublin in February 2018.

Words by Elaine Burke